logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-22. Secondary drugs cited by clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (ii) Inpatient units

Secondary drugNumber of citations by all clients%
Volatile Inhalants3651.2%
Other Substances7452.4%
Hypotics and Sedatives357911.5%
Total number of citations31136100%


 The countries supplying data are: BE, BG, CZ, DK, IE, GR, FR, CY, LU, HU, NL, AT, RO, SK, FI, SE, UK, HR, TR. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also 'General notes for interpreting data' on the Explanatory notes and help page


 Reitox national reports 2010 — Table TDI by centre type.  

(see the help page for information about formats etc.)

Page last updated: Thursday, 30 June 2011